These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27836809)

  • 1. Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination.
    Su YY; Huang SJ; Guo M; Zhao J; Yu H; He WG; Jiang HM; Wang YJ; Zhang XF; Cai JP; Yang CL; Wang ZZ; Zhu FC; Wu T; Zhang J; Xia NS
    Clin Microbiol Infect; 2017 May; 23(5):336.e1-336.e4. PubMed ID: 27836809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the long-term antibody response of a hepatitis E vaccine.
    Chen S; Zhou Z; Wei FX; Huang SJ; Tan Z; Fang Y; Zhu FC; Wu T; Zhang J; Xia NS
    Vaccine; 2015 Aug; 33(33):4124-9. PubMed ID: 26126668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
    Zhu FC; Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Wang H; Yang CL; Jiang HM; Cai JP; Wang YJ; Ai X; Hu YM; Tang Q; Yao X; Yan Q; Xian YL; Wu T; Li YM; Miao J; Ng MH; Shih JW; Xia NS
    Lancet; 2010 Sep; 376(9744):895-902. PubMed ID: 20728932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity.
    Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Yao X; Liang ZL; Wu T; Li JX; Yan Q; Yang CL; Jiang HM; Huang HJ; Xian YL; Shih JW; Ng MH; Li YM; Wang JZ; Zhu FC; Xia NS
    Clin Microbiol Infect; 2014 Jun; 20(6):O397-405. PubMed ID: 24118636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years.
    Yu XY; Chen ZP; Wang SY; Pan HR; Wang ZF; Zhang QF; Shen LZ; Zheng XP; Yan CF; Lu M; Chen B; Zheng Y; Zhang J; Lv HK; Huang SJ
    Vaccine; 2019 Jul; 37(32):4581-4586. PubMed ID: 31262585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific memory B cell response and participation of CD4
    Kulkarni SP; Thanapati S; Arankalle VA; Tripathy AS
    Vaccine; 2016 Nov; 34(48):5895-5902. PubMed ID: 27997340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
    Zaman K; Dudman S; Stene-Johansen K; Qadri F; Yunus M; Sandbu S; Gurley ES; Overbo J; Julin CH; Dembinski JL; Nahar Q; Rahman A; Bhuiyan TR; Rahman M; Haque W; Khan J; Aziz A; Khanam M; Streatfield PK; Clemens JD
    BMJ Open; 2020 Jan; 10(1):e033702. PubMed ID: 31959609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice.
    Tao W; Zheng HQ; Fu T; He ZJ; Hong Y
    Hum Vaccin Immunother; 2017 Aug; 13(8):1818-1822. PubMed ID: 28604244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.
    Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS
    Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.
    Sanford BJ; Opriessnig T; Kenney SP; Dryman BA; Córdoba L; Meng XJ
    Vaccine; 2012 Sep; 30(44):6249-55. PubMed ID: 22906724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy.
    Sridhar S; Situ J; Cai JP; Yip CC; Wu S; Zhang AJ; Wen L; Chew NF; Chan WM; Poon RW; Chan JF; Tsang DN; Chen H; Xia NS; Yuen KY
    J Hepatol; 2021 Jun; 74(6):1315-1324. PubMed ID: 33845058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new hepatitis E vaccines.
    Cao Y; Bing Z; Guan S; Zhang Z; Wang X
    Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections.
    Abravanel F; Lhomme S; Chapuy-Regaud S; Mansuy JM; Muscari F; Sallusto F; Rostaing L; Kamar N; Izopet J
    J Infect Dis; 2014 Jun; 209(12):1900-6. PubMed ID: 24436450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of 8G12 competitive antibody in "prime-boost" vaccination of Hepatitis E vaccine.
    Wu X; Chen P; Lin H; Su Y; Hao X; Cao Y; Li L; Zhu F; Liang Z
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28272983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of a hepatitis E vaccine.
    Zhang J; Zhang XF; Huang SJ; Wu T; Hu YM; Wang ZZ; Wang H; Jiang HM; Wang YJ; Yan Q; Guo M; Liu XH; Li JX; Yang CL; Tang Q; Jiang RJ; Pan HR; Li YM; Shih JW; Ng MH; Zhu FC; Xia NS
    N Engl J Med; 2015 Mar; 372(10):914-22. PubMed ID: 25738667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.
    Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V
    World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis E virus: Current epidemiology and vaccine.
    Wu X; Chen P; Lin H; Hao X; Liang Z
    Hum Vaccin Immunother; 2016 Oct; 12(10):2603-2610. PubMed ID: 27184971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients.
    Balayan MS; Fedorova OE; Mikhailov MI; Rytick PG; Eremin VF; Danilova TI; Shevelev BI; Gorbacheva EC; Pankova GY
    J Viral Hepat; 1997 Jul; 4(4):279-83. PubMed ID: 9278226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine.
    Liu P; Du Rj; Wang L; Han J; Liu L; Zhang Yl; Xia Jk; Lu Fm; Zhuang H
    PLoS One; 2014; 9(1):e87600. PubMed ID: 24498149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.